Introduction
Endometriosis is a common estrogen-dependent inflammatory condition, which is characterized by the growth of endometriotic lesions consisting of endometrial glands and stroma outside the uterus and is associated with pelvic pain and infertility (Giudice 2010) . The exact prevalence of endometriosis is unknown but is estimated to range from 2 to 10% of reproductive age women, and rise up to 50% of infertile women (Meuleman et al. 2009 ). The precise etiology and pathogenesis of endometriosis still remain controversial despite extensive research. Among these, the most widely accepted theory is Sampson's theory of implantation of endometrial cells and fragments refluxed through the fallopian tubes during the menstrual period (Sampson 1927) . According to this theory, a puzzle emerges that only 6-10% of women develop endometriosis, whereas retrograde menstruation is observed in most women, suggesting that other factors may also trigger the formation of endometriotic lesions, such as hormones, cytokines, growth factors, angiogenic factors and cancer-related molecules (Giudice & Kao 2004) .
Immunocytes are thought to play an important role in the origin and development of endometriosis. The dysfunction of immune cells and their mediators are responsible for the poor clearance of ectopic endometrium. Moreover, they promote ectopic implantation and growth of endometrium. Macrophages, which are recruited to the peritoneal cavity and mainly present M2 phenotype, account for 80% of all lymphocytes in the peritoneal fluid. Some studies have shown that the total number, concentration and activated status of peritoneal macrophages are higher in women with endometriosis (Haney et al. 1981 , Halme et al. 1984 , Halme et al. 1987 , Dunselman et al. 1988 .
Melanoma differentiation-associated gene-7 (mda-7)/ interleukin-24 (IL-24), a member of IL-10 gene family, is a newly discovered tumor-suppressing protein . It can bind to its two different heterodimeric receptor complexes, IL-20R1/IL-20R2 and IL-22R/IL-20R2 (Dumoutier et al. 2001) . As a dualacting cytokine, IL-24 participates in normal immune response as a cytokine at normal physiological levels. At supraphysiological levels, IL-24 displays prominent anti-tumor biological properties such as promoting the apoptosis of tumor cells, inhibiting the angiogenesis and the invasion of tumor cells and enhancing the sensitivity to radiotherapy, without affecting normal cells , Sauane et al. 2008 . MDA-7/ IL-24 has now proven efficacious and secure in a phase I/II clinical trial in humans with multiple advanced cancers (Dent et al. 2010) . Our previous study showed that DSCs expressed IL-24 and its receptors in human during early pregnancy, and estrogen promoted the growth of DSCs by downregulating the level of IL-24 (Shao et al. 2013) .
Although endometriosis is a benign estrogendependent disease, endometriosis and cancer are similar in several aspects such as uncontrolled cell growth and invasion (Ueda et al. 2002) . Therefore, this study was undertaken to clarify the role and mechanism of IL-24 and its receptors (IL-20R1, IL-20R2 and IL-22R1) in biological functions' regulation of ESCs induced by cross-talking between macrophages and ESCs.
Materials and methods

Tissue collection
This study was approved by the Ethical Committee of the Obstetrics and Gynecology Hospital, Fudan University. All tissue samples were obtained with the consent of the patients. The study's subjects were women of reproductive age attending the Obstetrics and Gynecology Hospital of Fudan University between March 2015 and January 2016. By laparoscopy and histological analysis, endometriosis was confirmed. According to the revised American Fertility Society classification of endometriosis, all the women with endometriosis were classified as stages III/IV (American Fertility Society 1985) , and none of the women had received hormonal medication in the 6 months before the surgical procedure. Endometriotic cyst wall tissues (ectopic endometrium) (n = 10) were obtained from women between ages 23 and 46 years during surgeries. The endometrial tissues were obtained from fertile women (ages 25-45 years) with (n = 38) or without (n = 10) endometriosis as control. All the samples were confirmed histologically according to the established criteria. The tissues used for immunohistochemistry were obtained during both the proliferative and secretory phases of the cycle, but for all other experiments, the samples were collected only in the proliferative phase of the cycle.
The endometrial tissues from women with endometriosis were collected under sterile conditions and transported to the laboratory on ice in Dulbecco's modified Eagle's medium (DMEM)/F-12 (Gibco) with 10% fetal calf serum (FCS; Hyclone, Logan, UT, USA).
Peripheral blood samples (15 mL) from the healthy women were taken sterilely in heparinized Hank's buffer solution (Gibco) before the administration of anesthesia. The samples were immediately transported to a laboratory on ice for bead sorting of the monocytes.
Immunohistochemistry
Paraffin sections (5 µm) of the endometriotic cyst wall tissue and eutopic endometrial tissues from women with or without endometriosis in the proliferative or secretory phase of the cycle were dehydrated in graded ethanol and incubated with 3% hydrogen peroxide in 1% bovine serum albumin in Trisbuffered saline (TBS) to block endogenous peroxidase. The samples were then incubated with mouse anti-human IL-24 monoclonal antibody (25 µg/mL; R&D Systems), IL-20R1 antibody (15 μg/mL; R&D Systems), IL-20R2 antibody (SC-99085; 1:100; Santa Cruz Biotechnology), IL-22R1 antibody (15 μg/mL; R&D Systems) or mouse/rabbit IgG isotype (SinoAmerica Co, Ltd, Shanghai, China) overnight at 48°C in a humid chamber. After washing three times with TBS, the sections were overlaid with peroxidase-conjugated goat anti-mouse/ rabbit IgG (Golden Bridge International, Inc, Beijing, China), and the reaction was developed with 3,3-diaminobenzidine and counterstained with hematoxylin. The experiments were repeated three times with 12 different samples.
Cell isolation and culture
According to the previous methods (Li et al. 2012 , the ESCs of eutopic endometrium from women with endometriosis (eutopic ESCs) and peripheral monocytes were isolated. For isolation of ESCs, the endometrial tissues were digested with collagenase type IV (0.1%; Sigma) for 30 min at 37°C with constant agitation for recovering ESCs. To remove cellular debris, the tissue pieces were filtered through sterile gauze pads (pore diameter sizes: 200 mesh). After gentle centrifugation, the supernatant was discarded, and the cells were re-suspended in DMEM/F-12. The ESCs were separated from epithelial cells by passing them over sterile gauze pads (pore diameter sizes: 400 mesh). The filtrated suspension was layered over Ficoll and centrifuged at 800 g for 20 min to further remove leukocytes and erythrocytes, and the middle layer was collected and then washed with D-Hanks solution. The ESCs were placed in a culture flask and allowed to adhere for 20 min. The adherent stromal cells were cultured as monolayer in flasks with DMEM/F-12 supplemented with 10% FCS and 20 mmol/L HEPES and incubated in a humidified incubator with 5% CO 2 at 37°C. These methods supplied 
CD14
+ monocytes were purified from PBMC by magnetic affinity cell sorting (MACS) using the human CD14 MicroBeads kit (Miltenyi Biotec GmbH, Germany). The purity of CD14 + monocytes was >95% as determined by flow cytometry. Subsequently, these monocytes were differentiated to macrophages in vitro according to previous method . Specifically, the monocytes were stimulated with granulocyte macrophage colony-stimulating factor (GM-CSF, 5 ng/mL; R&D Systems) and macrophage colony-stimulating factor (M-CSF, 20 ng/mL; R&D Systems) in RPMI-1640 medium (Gibco) containing 10% FBS and 2 mM l-glutamine for up to 6 days. The medium that contained GM-CSF and M-CSF was changed every 3 days. After 6 days, the monocyte-derived macrophages were further incubated with ESCs in contact co-culture units for another 2 days.
Bromodeoxyuridine (BrdU) cell proliferation and Matrigel invasion assays
The isolated eutopic ESCs from women with endometriosis were treated with recombinant human IL-24 (rhIL-24, at 0, 1, 10 or 100 ng/mL) or anti-IL-24 neutralizing antibody (α-IL-24, at 0, 0.05, 0.5, or 5 μg/mL) for 24 or 48 h. In addition, mouse isotype (1 mg/mL) (Sino-America Co, Ltd) or media as a negative Figure 1 The expression of IL-24 is decreased in the eutopic and ectopic endometrium of women with endometriosis. The expression of IL-24 and its receptors (IL-20R1, IL-20R2 and IL-22R1) in the endometrium of women without endometriosis (n = 10), eutopic endometrium (n = 10) and ectopic lesion (n = 10) from women with endometriosis were analyzed by immunohistochemistry. Original magnification: ×200. Normal: endometrium of women without endometriosis; eutopic: endometrium of patient with endometriosis; ectopic: endometriotic tissues; PP, proliferative phase; SP, secretory phase. control was added. Then the ability of ESCs proliferation was detected by BrdU cell proliferation assay kits (Millipore) according to the manufacturer's instruction. The experiments were performed in triplicate, and repeated four times.
In addition, the invasion of the eutopic ESCs from women with endometriosis was analyzed by Matrigel invasion assay, following our previous procedure (Li et al. 2012) . Briefly, the cell inserts (8 µm pore size, 6.5 mm diameter, Corning) coated with 15-25 µL Matrigel were placed in a 24-well plate. The ESCs of 2 × 10 4 were plated in the upper chamber. Recombinant human IL-24 protein (100 ng/mL) or the vehicle was added. The lower chamber was filled with 800 µL medium. Primary ESCs (n = 6) from eutopic endometrium with endometriosis were incubated with different concentrations of rhIL-24 (0, 1, 10 and 100 ng/mL for (A); 100 ng/ml for (c)), anti-IL-24 neutralizing antibody (0, 0.05, 0.5 and 5 µg/mL) for 48 h, the mouse isotype or media were added to some wells as a negative control, and then BrdU proliferation assay (A and B) and Matrigel invasion assay (C) were used to detect the proliferation and invasiveness of ESCs. The invasion index was calculated as (the ratio of the cells number migrated to the lower surfaces in each group/the vehicle control)*100. Original magnification: ×200. Data are expressed as the mean ± s.e.m. *P < 0.05 or **P < 0.01 compared with the control. The cells were then incubated at 37°C for 48 h. The inserts were removed, washed in PBS and the non-invading cells together with the Matrigel were removed from the upper surface of the filter by wiping with a cotton bud. The inserts were then fixed in methanol for 10 min at room temperature and stained with hematoxylin. The result was observed under Olympus BX51+P70 microscope (Olympus). The cells that migrated to the lower surfaces were counted in five predetermined fields at a magnification of ×200. Each experiment was carried out in triplicate, and repeated three times.
Flow cytometry (FCM)
The eutopic ESCs from women with endometriosis were cultured in 24-well plates (Corning) at a density of 1 × 10 5 cells/ well. In the contact co-culture unit, the monocytes-derived Figure 4 The effect of macrophages on Ki-67 and PCNA expression of ESCs is dependent on IL-24. The eutopic ESCs (n = 6) from women with endometriosis were co-cultured with or without monocytes plus rhIL-24 (100 ng/mL) or not for 48 h, respectively. Then the expression of Ki-67 and PCNA in Vimentin + ESCs (A) was detected by FCM (B and C), respectively. Co: co-culture of ESC and monocytes-derived macrophages. Co+rhIL-24: co-culture of ESC and monocytes-derived macrophages plus rhIL-24. All data are expressed as the mean ± s.e.m. *P < 0.05 or ***P < 0.001 compared with control; # P < 0.05 or ### P < 0.001 compared with co-culture group; $$$ P < 0.001 compared with rhIL-24 alone. NS, no significant difference.
Figure 5
The effect of macrophages on COX-2 and CD82 expression of ESCs is dependent on IL-24. The ESCs (n = 6) were treated as described in Fig. 4 , then the expression of CD82, COX-2 and IDO in Vimentin + ESCs was detected by FCM (A and B), respectively. All data are expressed as the mean ± s.e.m. *P < 0.05, **P < 0.01 or ***P < 0.001 compared with control; # P < 0.05 compared with co-culture group; $$ P < 0.01 or $$$ P < 0.001 compared with rhIL-24 alone.
macrophages from peripheral blood of healthy women were directly added to the wells at the same density as the ESCs, and further stimulated with or without rhIL-24 (100 ng/mL) for another 48 h. The cultured eutopic ESCs alone in the same media were used as the control. After co-culture, the expression of IL-24 (R&D Systems), IL-20R1 (R&D Systems), IL-22R1 (R&D Systems), Ki-67 (BioLegend, USA), PCNA (BioLegend, San Diego, CA, USA), CD82 (BioLegend), COX-2 (Cell Signaling Technology) and Indoleamine 2,3-dioxygenase-1 (IDO1) (Cell Signaling Technology) on Vimentin + ESCs (R&D Systems) was analyzed by flow cytometry, and the corresponding isotypic control antibodies were used.
Statistics
All values are shown as mean ± s.e.m. The data were analyzed by a t-test in the case of two groups or by a one-way ANOVA using Tukey's post hoc test in multiple groups (SPSS, version 11.5). The differences were considered as statistically significant at P < 0.05.
Results
The expression of IL-24 is decreased in the eutopic and ectopic ESCs from women with endometriosis
To investigate whether IL-24 and its receptors are expressed in ESCs, we compared the expression level of IL-24 and its receptors (IL-20R1, IL-20R2 and IL-22R1) proteins in the endometrium with or without endometriosis. As depicted in Fig. 1 , we found that the expression of IL-24 and its receptor IL-20R2 in normal endometrium was significantly higher than that in eutopic and ectopic endometrium from women with endometriosis. Moreover, the positive expression of IL-24 and IL-20R2 was observed in both endometrial stromal and epithelial cells. However, IL-22R1 expression in all endometrium tissues was very low. There was the highest level of IL-20R1 in eutopic endometrium from women with endometriosis. These results suggest that the lower expression of IL-24 and its receptor IL-20R2 in eutopic and ectopic endometrium stromal cells may participate in regulating the biological behaviors of ESCs, and further be involved in the origin and development of endometriosis.
IL-24 suppresses the proliferation and invasiveness of ESCs
To further probe the role of IL-24 in regulating biological behavior of ESCs, we evaluated its effect on proliferation and invasiveness of ESCs in vitro. As shown in Fig. 2 , rhIL-24 significantly decreased the proliferation of the ESCs after treatment for 48 h (P < 0.05 or P < 0.01), especially at the concentration of 100 ng/mL ( Fig. 2A) . Conversely, blocking IL-24 with anti-human IL-24 antibodies (α-IL-24) notably promoted the proliferation of ESCs (P < 0.05 or P < 0.01) (Fig. 2B) . Meanwhile, rhIL-24 obviously suppressed the invasiveness of ESCs (P < 0.01) (Fig. 2C) . Our results suggest that IL-24 in vitro suppresses the proliferation and invasion of ESCs in an autocrine manner.
Figure 6
Macrophages promote the viability and invasion of ESCs partly by IL-24 suppression. The ESCs (n = 6) were treated as described in Fig. 4 , then BrdU proliferation (A) and Matrigel invasion (B) were performed to examine the proliferation and invasiveness in ESCs. All data are expressed as the mean ± s.e.m. **P < 0.01 or ***P < 0.001 compared with control; 
Macrophages downregulate the expression of IL-24 and IL-20R1 in ESCs
To evaluate whether macrophages regulate the expression of IL-24 and its receptors in ESCs, we constructed a contact co-culture model with Vimentin + eutopic ESC from endometriosis and human monocytesderived macrophages (Fig. 3A) . As shown, co-culture with macrophages led to low levels of IL-24 (Fig. 3B ) and IL-20R1 (Fig. 3C and D left) in ESCs (P < 0.0001). However, there was no difference in IL-22R1 expression (P > 0.05) (Fig. 3C and D left) . The data indicate that macrophages in endometriotic milieu may regulate biological behaviors of ESCs by downregulating IL-24 and its receptor.
The effect of macrophages on Ki-67, PCNA, COX-2 and CD82 expression of ESCs is dependent on IL-24
It is reported that COX-2 (Matsuzaki et al. 2004 , Kao et al. 2011 , IDO1 (Mei et al. 2013 ) and CD82 (Li et al. 2011) are involved in modulating the proliferation and or invasiveness of ESCs. To investigate the role of IL-24 and macrophages on these proliferation-related and invasion-related molecules in ESCs (Fig. 4A ), ESCs were treated with or without rhIL-24 after co-culture with or without macrophages. As shown in Figs 4 and 5, macrophages significantly upregulated the expression of Ki-67, PCNA and COX-2 and downregulated the expression of CD82 in ESCs in co-culture units (P < 0.01 or P < 0.001) (Figs 4B, C and 5A, B). However, exposure with rhIL-24 resulted in an opposite effect on these molecules in ESCs (P < 0.05, P < 0.01 or P < 0.001) (Figs 4B, C and 5A, B) . In addition, rhIL-24 could partly or completely reverse the effect of macrophages on Ki-67, PCNA, CD82 and COX-2 expression (Figs 4B, C and 5A, B).
Macrophages promotes the viability and invasion of ESCs partly by IL-24 suppression
Finally, to investigate the impact of macrophages on ESCs behavior and to explore whether this effect is dependent on regulation of IL-24, BrdU proliferation and Matrigel invasion assays were performed to examine the proliferation and invasiveness of ESCs respectively. Consistent with the level of proliferation-related and invasion-related molecules, macrophages could markedly promote the proliferation and invasiveness of ESCs in ESCs-macrophages co-culture unit (P < 0.001) ( Fig. 6A and B) . Treatment with IL-24 inhibited the proliferation and invasiveness of ESCs (P < 0.01) (Fig. 6A and B), and partly downregulated the stimulatory effect of macrophages on the viability and invasion of ESCs ( Fig. 6A and B) . These results described previously suggest that the abnormally low IL-24 induced by macrophages results in the increase of Ki-67, PCNA and COX-2, a decrease of CD82 level in ESCs and the upregulation of proliferation and invasion in ESCs, and further contributes to development of endometriosis.
Discussion
Our previous research has proved that estrogen promotes proliferation and growth of DSCs by downregulating IL-24 in early pregnancy (Shao et al. 2013) . In this study, we first demonstrated that the expression of IL-24 and its receptors in eutopic and ectopic ESCs derived from patients with endometriosis was decreased. The absence of IL-24 led to the increase of proliferation and invasion of ESCs in vitro. As an estrogen-dependent disease, endometriosis is defined as the presence of endometriallike tissue outside the uterine cavity, the implantation and growth of the retrograded endometrial cells into the peritoneum is a key step for endometriosis (Witz et al. 2001) . Therefore, IL-24 may be also involved in the effect of estrogen on endometriosis.
After binding to its receptor dimers IL-20R1/IL-20R2 or IL-22R1/IL-20R2, MDA-7/IL-24 plays a lot of physiological and pathological functions (Dumoutier et al. 2001) . Here, we found that IL-20R2 expression was also abnormally low in eutopic endometrium and ectopic lesions from patients with endometriosis. Blocking IL-24 could upregulate the proliferation of ESCs. On the contrary, rhIL-24 inhibited ESCs proliferation in a dosage-dependent manner. These data suggest that both endogenous and exogenous IL-24 play an inhibitory effect on ESCs growth. Many studies demonstrate that the suppressing effects on tumor growth are mediated mainly by IL-24-activated apoptotic pathways. IL-24 induces cell death through the activation of PKR, such as endoplasmic reticulum kinase (PERK), an unfolded protein response sensor. IL-24 can prevent the interaction between the endoplasmic reticulum (ER)-residing chaperone protein BiP/GRP78 and PERK, which results in the oligomerization and autophosphorylation of PERK . These events decrease the expression of pro-survival proteins (such as Mcl-1, Bcl-XL, Bcl-2 and c-Flip) and increase levels of proapoptotic markers (such as Bax and Bak) , Yacoub et al. 2008 . Moreover, IL-24 mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the growth arrest and DNA damage (GADD) (Sarkar et al. 2002) . Our current results show that the decrease of IL-24 in ESCs leads to the increase of Ki-67, PCNA and COX-2 of ESCs. It may also give rise to a downregulation of ESCs apoptosis.
Activation of PERK triggers the vacuolization of LC3 protein and results in an increased expression of autophagy markers (ATG5 and Beclin-1) and also induced an increased level of ROS, which leads to an increase of IL-24-mediated toxic autophagy and apoptosis (Yacoub et al. 2008) . The autophagy level in the ectopic endometriotic tissue is decreased, and the low level of autophagy is dependent on the estrogen/ CXCL12 axis in ESCs and involved in the pathogenesis of endometriosis (Mei et al. 2015) . Interestingly, IL-24 can inhibit lung tumor cells migration by disrupting the CXCL12/CXCR4 signaling pathway (Panneerselvam et al. 2015) . Therefore, the absence of IL-24 in ESCs may also participate in the process of estrogen-CXCL12/ CXCR4 axis on autophagy regulation of ESCs. This area will require further research.
On this basis, we further found IL-24-promoted CD82 expression and inhibited COX-2 expression and invasiveness of ESCs in vitro. It has been reported that IL-24 also plays a role in inhibiting tumor invasion and metastasis by downregulating the expression of metastasis-related genes such as CD44, intercellular cell adhesion molecule-1 (ICAM-1), matrix metalloproteinase (MMP)-2, MMP-9, survivin, TGF-β, and the activation of Akt and NF-κB signaling pathways (Huo et al. 2013) . CD82 can restrict the invasiveness of ESCs by increasing the expression of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP2 (Li et al. 2011) . These actions indicate that the declining level of IL-24 may cause the enhancement of ESCs invasion by downregulating COX-2 and up-regulating CD82 and its downstream signals (such as TIMPs). However, this action of IL-24 may be independent on IDO.
The ectopic localization of endometrial tissue fragments implies survival and proliferation in a local microenvironment with a prerequisite of immune tolerance. It elicits a series of immune responses including recruitment of macrophages, blood vessels, cytokines and nerve fibers into the resultant lesions (Cao et al. 2004 , Asante & Taylor 2011 , Burney & Giudice 2012 . Macrophages are functionally polarized into the classically activated macrophages phenotype (M1) and the alternatively activated macrophages phenotype (M2), which is alternatively activated in the inflammatory peritoneal fluid and in the endometriotic lesions (Bacci et al. 2009 ). Our and other researches have proven that macrophages are involved in ectopic adhesion, implantation, growth and vascularization of the endometriotic tissue (Bacci et al. 2009 , Capobianco et al. 2011 , Li et al. 2012 , and estradiol may lead to the development of endometriosis by inducing M2 polarization of macrophages (Wang et al. 2015) . Therefore, macrophages are thought to have a pivotal role in the development and maintenance of endometriosis. In this study, macrophages can downregulate IL-24 and its receptor IL-22R1 expression, and further promote proliferation and invasion of ESCs, suggesting that IL-24 may also be involved in the regulatory functions of macrophages on ESCs.
Besides regulation of ESCs invasiveness, CD82 decreases the secretion of chemokine CCL2 by ESCs, and possibly participates in controlling the recruitment of macrophages to ectopic lesions in endometriosis (Li et al. 2011) . The suppression of CD82 by macrophages-IL-24 signal may stimulate the production of CCL2 by ESCs, and further induce the accumulation of macrophages in endometriotic milieu, and from a positive feedback. COX-2 and its derivative prostaglandin E 2 (PGE 2 ) have also been proven to play a key role in the origin and development of endometriosis through multiple mechanisms, including increased migration and invasiveness (Matsuzaki et al. 2004 , Carli et al. 2009 , Kao et al. 2011 , Sacco et al. 2012 . Previous studies have suggested that COX-2 expression is increased in the eutopic endometrium and the ovarian endometriotic tissue of patients with endometriosis (Cho et al. 2010) and its derivative PGS, particularly PGE2, can explain most of the symptoms of endometriosis (Chishima et al. 2002) , especially the induction of pain. In addition, PGE2 can inhibit CD36-dependent phagocytosis of macrophages in endometriosis (Chuang et al. 2010) . Therefore, macrophages increase COX-2 expression of ESCs by downregulation of IL-24 in the macrophages-ESCs co-culture unit, and may further induce the production of PGE 2 . In turn, PGE 2 leads to the decreased scavenger activity of macrophages and further accelerates the development of endometriosis. Further experiments are needed to verify this conjecture. Figure 7 Schematic representation of the roles of IL-24 in the crosstalk between ESCs and macrophages in endometriosis. IL-24 inhibits the expression of Ki-67, PCNA and COX-2 and promotes the expression of CD82 in ESCs. However, macrophages can downregulate the expression of IL-24 and its receptors in ESCs, and then lead to increase in Ki-67, PCNA and COX-2, a decrease of CD82 level, and a high proliferation and invasion abilities of ESCs, and may further contribute to the survival, growth and implantation of ectopic endometrium, and finally promote the progression of endometriosis.
Collectively, based on this study and other reports, it can be concluded that the abnormally low level of IL-24 and its receptor in ESCs possibly induced by macrophages and or local high level of estrogen, on the one hand, leads to the increase of Ki-67, PCNA and COX-2 and a decrease of the CD82 level, and further stimulates the proliferation and invasion of ESCs (Fig. 7) ; on the other hand, this probably results in the recruitment of macrophages by CD82/CCL2 signal, and the impaired phagocytosis of macrophage by COX-2/PGE 2 axis, which finally contributes to the survival, growth and implantation of ectopic endometrium and promotes the progress of endometriosis. IL-24 may be a biomarker for the diagnosis and treatment for endometriosis. These potential values are worth further investigation.
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